Thompson, AJ; (1996) Multiple sclerosis: Symptomatic treatment. J NEUROL , 243 (8) 559 - 565.
Full text not available from this repository.
Reports of new therapeutic agents designed to suppress inflammatory processes in multiple sclerosis have excited much interest but, thus far, have had little influence on symptoms, disability and handicap in patients. The clinical application of recent advances in physcial, pharmacological and surgical approaches to management will, at least in the medium-term future, therefore offer significantly greater opportunities for improving the quality of life of patients with multiple sclerosis, Here, symptomatic treatment of the whole range of difficulties encountered by patients with multiple sclerosis is reviewed in the context of the multidisciplinary strategy crucial to an optimal outcome.
|Title:||Multiple sclerosis: Symptomatic treatment|
|Keywords:||Multiple sclerosis, symptomatic treatment, spasticity, incontinence, DOUBLE-BLIND, INTRATHECAL BACLOFEN, COGNITIVE DYSFUNCTION, BLADDER DYSFUNCTION, SEXUAL DYSFUNCTION, BOWEL DYSFUNCTION, BOTULINUM TOXIN, CLINICAL SIGNS, PAIN SYNDROMES, SPASTICITY|
|UCL classification:||UCL > School of Life and Medical Sciences > Faculty of Brain Sciences|
Archive Staff Only: edit this record